Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma
Clinical trial NCT05622136 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05622136
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-10
- Primary completion
- 2026-11-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.